FDA recall, , Moderate risk
American National Red Cross Red Blood Cells, Leukocytes Reduced, Irradiated
Red Blood Cells, Leukocytes Reduced, Irradiated may have been prepared incorrectly.
Recall ended Aug 28, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross began a recall of Red Blood Cells, Leukocytes Reduced, Irradiated on October 2, 2025, because arm preparation may have been performed incorrectly. The product was distributed in Missouri. The FDA added the recall to its Enforcement Report and classified it on August 28, 2026, and it was in the FDA's weekly enforcement report on September 9, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Recall details
- Company began the recall
- Sold in
- Company
- The American National Red Cross
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99426
- Recall number
- B-0188-2026
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
